Boston Common Asset Management, LLC Baxter International Inc Transaction History

Boston Common Asset Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 28, 2020	SELL	$76.7 - $88.45 $6.18 Million - $7.13 Million	-80,596 Closed	0 $0
Q3 2019 Nov 07, 2019	SELL	$81.4 - $89.78 $100,447 - $110,788	-1,234 Reduced 1.51%	80,596 $7.05 Million
Q2 2019 Jul 26, 2019	SELL	$73.44 - $82.41 $98,850 - $110,923	-1,346 Reduced 1.62%	81,830 $6.7 Million
Q1 2019 May 03, 2019	BUY	$64.48 - $81.31 $300,154 - $378,498	4,655 Added 5.93%	83,176 $6.76 Million
Q4 2018 Jan 25, 2019	SELL	$61.45 - $77.8 $16,591 - $21,006	-270 Reduced 0.34%	78,521 $5.17 Million
Q3 2018 Nov 01, 2018	SELL	$70.71 - $77.75 $258,445 - $284,176	-3,655 Reduced 4.43%	78,791 $6.07 Million
Q2 2018 Aug 06, 2018	BUY	$63.43 - $75.41 $165,869 - $197,197	2,615 Added 3.28%	82,446 $6.09 Million
Q1 2018 Apr 26, 2018	SELL	$62.56 - $72.26 $1.81 Million - $2.09 Million	-28,880 Reduced 26.57%	79,831 $5.19 Million
Q4 2017 Feb 07, 2018	BUY	$61.45 - $66.05 $257,106 - $276,353	4,184 Added 4.0%	108,711 $7.03 Million
Q3 2017 Nov 13, 2017	BUY	$59.5 - $64.61 $12,197 - $13,245	205 Added 0.2%	104,527 $6.56 Million
Q2 2017 Aug 14, 2017	BUY	N/A	104,322	104,322 $6.32 Million

1,006

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boston Common Asset Management, LLC with notifications on news.